These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6817452)

  • 21. Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
    Nakanishi H; Matsuoka I; Ono T; Nakahata N
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):255-67. PubMed ID: 8747793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
    Bevan J; Heptinstall S
    Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468).
    Van Nueten JM; Janssen PA; De Ridder A; Vanhoutte PM
    Eur J Pharmacol; 1982 Feb; 77(4):281-7. PubMed ID: 7060640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of ketanserin on 5-hydroxytryptamine-induced cerebrovascular spasm in the cat.
    Vällfors B; Dahlström A; Boström S; Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S60-3. PubMed ID: 2412061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.
    De Mey JG; Claeys M; Vanhoutte PM
    J Pharmacol Exp Ther; 1982 Jul; 222(1):166-73. PubMed ID: 6806467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.
    De Clerck F; Loots W; Somers Y; Beetens J; Wouters L; Wynants J; Janssen PA
    Br J Pharmacol; 1990 Apr; 99(4):631-6. PubMed ID: 2113823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
    Lai FM; Tanikella T; Cervoni P
    J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.
    Feniuk W; Humphrey PP; Perren MJ; Watts AD
    Br J Pharmacol; 1985 Nov; 86(3):697-704. PubMed ID: 2933110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketanserin and vascular contractions in response to cooling.
    Van Nueten JM; De Ridder W; Vanhoutte PM
    Eur J Pharmacol; 1984 Apr; 99(4):329-32. PubMed ID: 6734731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profile of a new potent 5-hydroxytryptamine (5-HT2) alpha 1-receptor antagonist.
    Schröder G; Beckmann R; Gerbling KP; Loge O; Maass B; Müller B; Seidelmann D; Schneider HH; Schulz BG; Stürzebecher CS
    Arzneimittelforschung; 1988 Jun; 38(6):765-70. PubMed ID: 2902861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J; Nabata H; Ishizuka N; Sakai K
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selectivity of calcium antagonism and serotonin antagonism with respect to venous and arterial tissues.
    Van Nueten JM; Vanhoutte PM
    Angiology; 1981 Jul; 32(7):476-84. PubMed ID: 7247071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.
    Monopoli A; Conti A; Forlani A; Ongini E; Antona C; Biglioli P
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():59-61. PubMed ID: 2285652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential vasomotor action of noradrenaline, serotonin, and histamine in isolated basilar artery from rat and guinea-pig.
    Chang JY; Hardebo JE; Owman C
    Acta Physiol Scand; 1988 Jan; 132(1):91-102. PubMed ID: 2906211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine-induced contractions of the isolated rat trachea are mediated by 5-hydroxytryptamine.
    Nordström O; Delbro D
    Acta Physiol Scand; 1986 Aug; 127(4):557-8. PubMed ID: 2944354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.